BRIACELL THERAPEUTICS CORP *W EXP 01/15/203

BRIACELL THERAPEUTICS CORP *W EXP 01/15/203 is a security (CUSIP 107930125) tracked across SEC portfolio filings. 14 institutional managers reported $3.7M on Form 13F as of 2026-06-30.

Summary

Top institutional holders (Form 13F)

ManagerLocationValueShares
CITADEL ADVISORS LLCMIAMI, FL$1.0M1,048,759
ARMISTICE CAPITAL, LLCNEW YORK, NY$553K536,600
SABBY MANAGEMENT, LLCSpicewood, TX$392K380,686
Cable Car Capital, LPSAN FRANCISCO, CA$332K321,898
Empery Asset Management, LPNew York, NY$309K300,000
HEIGHTS CAPITAL MANAGEMENT, INCSAN FRANCISCO, CA$300K300,000
MYDA Advisors LLCWOODMERE, NY$206K200,000
Hudson Bay Capital Management LPGreenwich, CT$125K125,402
Warberg Asset Management LLCWINNETKA, IL$118K115,000
Clear Street Group Inc.NEW YORK, NY$107K104,196
BOOTHBAY FUND MANAGEMENT, LLCNEW YORK, NY$84K20,000
IRIDIAN ASSET MANAGEMENT LLC/CTWESTPORT, CT$58K65,000
LuminArx Capital Management LPNEW YORK, NY$26K25,000
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$24K23,889

More